GGrantIndex
Sort

51,593 grants matching hepatitis

Multi-Center Validation and Biologic Assessment of a Novel Pre-Transplant Biomarker Panel to Predict Liver Transplant Recipient Mortality

$677,481
Keri Elizabeth Lunsford · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DK

Medication Adherence in Children Who Had a Liver Transplant (MALT)

$677,432
Eyal Shemesh · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · DK

Mechanisms of Behavior Change Resource Core for Alcohol-HIV Interventions

$677,393
Christopher W. Kahler · Brown University · U24 · FY2014 · AA

Clinical Core

$677,331
Richard Douglas Moore · Johns Hopkins University · P30 · FY2017 · AI

Restoring Central Regulation of Glucose Production in Type 2 Diabetes

$677,112
Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2025 · DK

Gluconeogenesis and Glycogenolysis - Role and Regulation

$677,102
Dale S Edgerton · Vanderbilt University · R01 · FY2025 · DK

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail

$676,978
Robert P Schwartz · Friends Research Institute, Inc. · U01 · FY2014 · DA

Predicting post-transplant mortality and global functional health based on pre-transplant functional status in liver transplantation

$676,976
Jennifer C. Lai · University Of California, San Francisco · R01 · FY2020 · AG

Metabolic Actions of FGF21

$676,662
Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2015 · DK

Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver Disease

$676,642
Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2025 · DK

Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection

$676,524
Hee-Soon Juon · Thomas Jefferson University · R01 · FY2021 · DK

Indiana University Center for Pediatric Pharmacology and Precision Medicine

$676,502
Jamie L Renbarger · Indiana University Indianapolis · P50 · FY2020 · HD

A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph

$676,427
Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2014 · AA

Making Better Decisions: Policy Modeling for AIDS and Drug Abuse

$676,405
Douglas K Owens · Stanford University · R37 · FY2022 · DA

Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus

$676,330
Benjamin Doranz · Integral Molecular · N01 · FY2018 · AI

RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse

$676,263
Rae Jean Elizabeth Proeschold-Bell · Duke University · R01 · FY2014 · AA

Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics

$676,255
Sonia Michael Najjar · Ohio University Athens · R01 · FY2021 · MD

Community-based Self-management of HIV and Chronic Disease

$676,178
Sheryl L Catz · Kaiser Foundation Health Plan Of Washington · R01 · FY2008 · MH

Development of a topical malaria vaccine.

$676,165
Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2016 · AI

Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan

$676,058
Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2008 · DA

CCR FACS Core Laboratory

$675,994
Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Trial of Statins for Chemoprevention in Hepatocellular Carcinoma

$675,855
Raymond T Chung · Massachusetts General Hospital · R01 · FY2021 · CA

Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy

$675,803
Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2022 · GM

Clinical Trial of Short Course vs. INH for LTBI in Jail

$675,773
Mary Castle White · University Of California, San Francisco · U01 · FY2006 · AI

Working with HIV clinics to adopt addiction treatments using Implementation Facilitation (WHAT IF?)

$675,734
David Fiellin · Yale University · R01 · FY2017 · DA